DR. VIVEK VENKAT

Compassionate Evidence-Based Ethical Cancer Care

Call us at +919136041545
Best UroSurgeon in India

docvivek@gmail.com
Follow us on

WHAT IS PROSTATE CANCER SCREENING AND WHAT ARE ITS BENEFITS?

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, with the risk doubled in men with a positive family history. This makes it an important public health problem. As most men show no symptoms in the early curable stage, many national agencies recommend screening i.e. testing for the disease in order to diagnose it early. If not detected early, prostate cancer can be a common cause of death in men and screening has been proven to reduce death from prostate cancer.

WHO SHOULD BE SCREENED FOR PROSTATE CANCER?

All men aged 55-69 years should discuss screening for prostate cancer with their urologists.
Screening above the age of 70 needs to be individualized based on the man’s general health.
Those who have any urinary symptoms need to consult a urologist to determine if screening is needed.
Higher risk men including smokers, men of African descent and men with a positive family history should consider screening in their 40’s.

WHAT SCREENING TESTS ARE AVAILABLE FOR PROSTATE CANCER? WHAT IS THE PSA TEST?

A prostate examination (digital rectal examination) by your urologist is recommended annually above the age of 55 years.
The most important screening test remains a simple blood test known as Prostate-Specific Antigen (PSA). A low or normal PSA level usually indicates normal prostate health. An elevated PSA level (the normal range depends on age and other factors but generally is <4ng/ml) may signal a problem.

FAQs

What are the benefits of screening?

Early detection of prostate cancer with a chance of cure and improving survival.

What are the limitations of screening tests like the PSA?

Conditions like a benign enlargement of the prostate (BEP/ BPH) or prostate infection (prostatitis) can also raise the PSA. The only way to prove a cancer is by a biopsy.
Detection of slow-growing cancers leads to overdiagnosis and overtreatment. Newer tests and strategies are available today to reduce this problem.

Should I be screened for prostate cancer?

Do you have any difficulty or problems when passing urine?
Are you _________?
- I am 55-69 years old
- I am over 70 years old but in excellent health
- I have a family history of prostate cancer and I am between 40-69 years old. My father/ brother/ grand-father/ uncle/ son had prostate cancer
- I am of African descent and 40-69 years old

What should I discuss with my doctor about prostate cancer screening?

Pros and cons of PSA screening
Identify specific risk factors in your case
Further process if the PSA level is elevated
Follow-up needed in case PSA level is normal

Location 1:
Jewel Urology Center
No. 89, N. S. Road Number 1,
Navpada, JVPD Scheme,
Andheri West
Mumbai 400049, India
(m):+919136041545
Visiting Hours : Mon-Sat 4.30 - 6 pm
By appointments only
Email: appointments@drvivekvenkat.com
Phone:+919136041545
Whatsapp: +919136041545

Location 2:
Nanavati Max Hospital
S.V road, Vile Parle west
Mumbai 400056, India
Visiting Hours : Mon-Sat 2 - 4.30 pm
Email: appointments@drvivekvenkat.com
Phone:+919136041545
Whatsapp: +919136041545

Location 3:
Saifee Hospital
15/17, Maharshi Karve Rd,
Opposite Charni Road Station East,
Mumbai 400004, India
(m):+919136041545
Visiting Hours : Thursday 11am - 1 pm
By appointments only
Email: appointments@drvivekvenkat.com
Phone:+919136041545
Whatsapp: +919136041545

MAKE AN APPOINTMENT TODAY BY FILLING OUT THE FORM

Disclaimer: The purpose of this website (www.drvivek.com) is solely for the purpose of creating awareness and imparting education regarding plastic and cosmetic surgery. This shall not be treated as a substitute to a professional uro surgeon's advice or prescription. Every individual and their case is different, so the results of any of the treatments mentioned on the website may vary. This website contains graphic images of before and after results of procedures, so viewer discretion is advised.